BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20445199)

  • 1. Driving drug discovery: the fundamental role of academic labs.
    Silber BM
    Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
    Loregian A; Palù G
    Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities.
    Couvreur P; Barguer D; Crommelin DJ; Duchêne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E;
    Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539
    [No Abstract]   [Full Text] [Related]  

  • 5. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of new companies for drug discovery: origins of a decade of new drugs.
    Kneller R
    Nat Rev Drug Discov; 2010 Nov; 9(11):867-82. PubMed ID: 21031002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scripps Florida.
    Sheppard TL
    Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why and how have drug discovery strategies in pharma changed? What are the new mindsets?
    Mignani S; Huber S; Tomás H; Rodrigues J; Majoral JP
    Drug Discov Today; 2016 Feb; 21(2):239-49. PubMed ID: 26376356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium.
    Musselwhite LW; Maciag K; Lankowski A; Gretes MC; Wellems TE; Tavera G; Goulding RE; Guillen E
    Am J Trop Med Hyg; 2012 Jan; 86(1):65-74. PubMed ID: 22232453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIPTE: a multi-university partnership supporting academic drug development.
    Gurvich VJ; Byrn SR
    Drug Discov Today; 2013 Oct; 18(19-20):916-21. PubMed ID: 23732177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry Perspective on Biomarker Development and Qualification.
    Gerlach CV; Derzi M; Ramaiah SK; Vaidya VS
    Clin Pharmacol Ther; 2018 Jan; 103(1):27-31. PubMed ID: 29143971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of a molecular mechanism for actions of existing medicines and its application for drug development].
    Mizushima T
    Yakugaku Zasshi; 2012; 132(6):713-20. PubMed ID: 22687730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D Printing Pharmaceuticals: Drug Development to Frontline Care.
    Trenfield SJ; Awad A; Goyanes A; Gaisford S; Basit AW
    Trends Pharmacol Sci; 2018 May; 39(5):440-451. PubMed ID: 29534837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.